In the last trading session, 0.89 million shares of the Zai Lab Limited ADR (NASDAQ:ZLAB) were traded, and its beta was 1.06. Most recently the company’s share price was $24.84, and it changed around -$1.51 or -5.73% from the last close, which brings the market valuation of the company to $2.46B. ZLAB currently trades at a discount to its 52-week high of $31.22, offering almost -25.68% off that amount. The share price’s 52-week low was $13.48, which indicates that the current value has risen by an impressive 45.73% since then. We note from Zai Lab Limited ADR’s average daily trading volume that its 10-day average is 0.91 million shares, with the 3-month average coming to 640.51K.
Zai Lab Limited ADR stock received a consensus recommendation rating of Overweight, based on a mean score of 1.13. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended ZLAB as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Zai Lab Limited ADR is expected to report earnings per share of -0.76 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Zai Lab Limited ADR (NASDAQ:ZLAB) trade information
Instantly ZLAB has showed a red trend with a performance of -5.73% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 27.37 on recent trading dayincreased the stock’s daily price by 9.24%. The company’s shares are currently down -9.11% year-to-date, but still down -0.08% over the last five days. On the other hand, Zai Lab Limited ADR (NASDAQ:ZLAB) is 24.45% up in the 30-day period. We can see from the shorts that 5.42 million shares have been sold at a short interest cover period of 8.88 day(s).
The consensus price target as assigned by Wall Street analysts is $75.5, which translates to bulls needing to increase their stock price by 67.1% from its current value. Analyst projections state that ZLAB is forecast to be at a low of $50 and a high of $101.
Zai Lab Limited ADR (ZLAB) estimates and forecasts
Zai Lab Limited ADR share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 55.06 percent over the past six months and at a 15.71% annual growth rate that is well below the industry average of 17.60%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will loss -7.00% in revenue this quarter, and will report an increase of 22.00% in the next quarter. The year-over-year growth rate is expected to be 49.30%, up from the previous year.
Consensus estimates provided by 6 financial analysts predict the company will bring in an average of 104.56M in revenue for the current quarter. 6 analysts expect Zai Lab Limited ADR to make 110.52M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 69.23M and 65.83M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 51.00%. Forecasts for the next quarter put sales growth at 67.90%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -16.93%.
ZLAB Dividends
Zai Lab Limited ADR’s next quarterly earnings report is expected to be released in November.
Zai Lab Limited ADR (NASDAQ:ZLAB)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 2.18% of Zai Lab Limited ADR shares, and 50.98% of them are in the hands of institutional investors. The stock currently has a share float of 52.12%. Zai Lab Limited ADR stock is held by 161.0 institutions, with WELLINGTON MANAGEMENT GROUP LLP being the largest institutional investor. By 2024-06-30, it held 7.3211% of the shares, which is about 7.12 million shares worth $123.47 million.
JANUS HENDERSON GROUP PLC, with 6.7077% or 6.53 million shares worth $113.13 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
